AUSTIN, Texas, Sept. 9 /PRNewswire-FirstCall/ -- Luminex
Corporation (Nasdaq: LMNX) today announced that management will
present at UBS Global Life Sciences Conference to be held
September 20 - 22, 2010, in
New York City, New York.
(Logo:
http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
(Logo:
http://www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO)
The investor presentation by Patrick J.
Balthrop, president and chief executive officer, will begin
at 8:00 a.m. Eastern time on
Wednesday, September 22, 2010.
The presentation will be webcast live and may be accessed at
Luminex Corporation's website at http://www.luminexcorp.com.
Simply log on to the web at the address above, go to the
Company section and access the Investor Relations link.
Please go to the website at least 15 minutes prior to the
event to register, download and install any necessary audio/video
software. If you are unable to participate during the live webcast,
the presentation will be archived for six months on the website
using the 'replay' link.
About Luminex Corporation
Luminex Corporation develops, manufactures and markets
proprietary biological testing technologies with applications
throughout the diagnostic and life sciences industries. The
Company's xMAP(R) multiplex solutions include an open-architecture,
multi-analyte technology platform that delivers fast, accurate and
cost-effective bioassay results to markets as diverse as
pharmaceutical drug discovery, clinical diagnostics and biomedical
research, including the genomics and proteomics markets. The
Company's xMAP Technology is sold worldwide and is already in use
in leading clinical laboratories as well as major pharmaceutical,
diagnostic and biotechnology companies. Further information on
Luminex Corporation or xMAP Technology can be obtained at
www.luminexcorp.com.
Contact:
|
Harriss T. Currie
|
|
|
Vice President, Finance and
Chief Financial Officer
|
|
|
512-219-8020
|
|
|
hcurrie@luminexcorp.com
|
|
|
|
SOURCE Luminex Corporation
Copyright t. 9 PR Newswire